2 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Predictive in vitro diagnostics test for individualized tailoring of chemotherapy in primary breast cancer (ChemoPredict)
Date du début: 1 juil. 2015, Date de fin: 31 déc. 2015,
SIVIDON established a prototype diagnostic assay - the ChemoPredict test - to stratify high-risk breast cancer patients and to help in deciding whether to treat the patient with standard anthracycline-based chemotherapy without taxane or taxane-containing regimens. ChemoPredict was clinically validated in a large clinical phase III trial (FinHer) with 919 patients using a prospective-retrospective ...
Voir le projet
1
Participant partenaire
TERMINÉ
Genome-based biomarkers leading to validated molecular diagnostic tests for response prediction in breast cancer (RESPONSIFY)
Date du début: 1 févr. 2012, Date de fin: 31 janv. 2015,
Individualisation of cancer therapy based on standardized biomarker assays is one of the most demanding challenges in cancer medicine. In the RESPONSIFY consortium, we will integrate information on response prediction from different breast cancer types and methodologies into biomarker tests for targeted therapies in the clinical routine setting. Those tests will be developed for commercialisation ...
Voir le projet